With a CFA credential and a BS degree in Accounting and Finance from the Wharton School, I have over 18 years of experience in healthcare equity research, strategy, and investment management. I am currently a Principal at Nephron Research, a boutique research firm focused on life science tools, diagnostics, and animal health sectors, where I provide in-depth analysis and insights on small and mid cap companies. Previously, I was a Senior Director of Strategy and Investor Relations at Natera, a leading genetic testing and diagnostics company focused on women's health, oncology, and transplant. I partnered with Natera's executive leadership, business units and external stakeholders to effectively communicate Natera's investment story, key value propositions and scientific data. Between 2007-2021, I worked as a long-only buyside healthcare investor at Cramer Rosenthal McGlynn (2007-2015) and Fred Alger Management (2015-2021). I focused on life science tools, diagnostics, medical devices and animal health sectors.I have a superior understanding and comprehension of industry dynamics, companies, and equity markets under my coverage, and a proven ability to conduct fundamental analysis, problem solve, and communicate ideas across cross-functional teams. I am passionate about healthcare innovation and growth, and I am looking for new opportunities to learn, grow, and add value to the organizations.
